U.S. DoJ will not challenge Aetna-CVS deal - report

(Reuters) - Shares of CVS Health Corp and health insurer Aetna Inc rose more than 2 percent on Thursday after CNBC reported that the U.S. Justice Department will not challenge their planned merger.

CNBC said Bloomberg reported the news, citing trade publication Reorg Research.

CVS Health Corp and Aetna announced the $69 billion deal on Dec. 3 last year, arguing it would enable the companies to tackle soaring healthcare spending by offering lower-cost medical services in pharmacies.

Aetna and CVS declined to comment.